🇺🇸 FDA
Patent

US 12109260

Zika vaccines and immunogenic compositions, and methods of using the same

granted A61KA61K2039/5252A61K2039/54

Quick answer

US patent 12109260 (Zika vaccines and immunogenic compositions, and methods of using the same) held by Takeda Vaccines, Inc. expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Vaccines, Inc.
Grant date
Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K2039/5252, A61K2039/54, A61K2039/545, A61K2039/55505